Valens GroWorks Corp. (CSE: VGW) a multi-licensed, vertically integrated provider of cannabis products and services utilizing proprietary extraction processes, is pleased to announce that it has closed its previously announced bought-deal prospectus offering. The syndicate for the Offering was led by AltaCorp Capital Inc. as co-lead underwriter and sole bookrunner, along with Mackie Research Capital Corp. as co-lead underwriter, and including Beacon Securities Limited, pursuant to which the Company issued an aggregate of 12,820,513 units of the Company at a price of $1.95 per Unit, 1,130,977 common shares of the Company and 961,539 Common Share purchase warrants, as a partial exercise of the Underwriters’ over-allotment option for aggregate gross proceeds to the Company of $27,303,801.
The Company plans to use the net proceeds from the Offering to increase extraction capacity at the Company’s Kelowna facility, strategically increase the Company’s domestic geographic presence, and for general corporate purposes.
The securities issued pursuant to the Offering have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from the registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any State in which such offer, solicitation or sale would be unlawful.
About Valens GroWorks
Valens GroWorks Corp. is a vertically integrated provider of Canadian cannabis products developed from our proprietary extraction techniques, with three wholly-owned subsidiaries located in and around Kelowna, BC. Subsidiary Valens Agritech has initiated cannabis production, processing and sales under a Health Canada Dealer’s Licence, which includes a supply agreement with Canopy Growth Corporation under their extensive CraftGrow distribution network. Subsidiary Supra THC Services is a Health Canada licensed ISO 17025 accredited cannabis testing lab providing sector-leading analytical services and has partnered with Thermo Fisher Scientific to develop a Centre of Excellence in Plant Based Medicine Analytics. Subsidiary Valens Farms is in the process of becoming a purpose-built facility in compliance with European Union (EU) Good Manufacturing Practices (GMP) standards, ensuring the product from this facility can be exported anywhere in the world where Cannabis is nationally legal for medical or adult usage purposes.
Netcoins Holdings Inc. (CSE: NETC) (OTC: GARLF) (WKN: 1WJ) is ple... READ MORE
Organigram Holdings Inc. (TSX-V: OGI) (OTCQX: OGRMF), the parent ... READ MORE
Fimbrion Therapeutics, Inc. announced that under its joint resear... READ MORE
Boralex Inc. (TSX:BLX) is pleased to announce commercial co... READ MORE
ATS Automation Tooling Systems Inc. (TSX: ATA) an industry-leadin... READ MORE